The document discusses diabetes, including:
- Diabetes is characterized by hyperglycemia due to defects in insulin secretion or action. The incidence is increasing globally.
- There are three main types: type 1 caused by autoimmune destruction of beta cells; type 2 associated with insulin resistance; and other specific types.
- Treatment goals are to prevent complications and death through education, insulin therapy, diet, exercise and monitoring of blood glucose and HbA1c levels.
The document discusses diabetes, including:
- Diabetes is characterized by hyperglycemia due to defects in insulin secretion or action. The incidence is increasing globally.
- There are three main types: type 1 caused by autoimmune destruction of beta cells; type 2 associated with insulin resistance; and other specific types.
- Treatment goals are to prevent complications and death through education, insulin therapy, diet, exercise and monitoring of blood glucose and HbA1c levels.
The document discusses diabetes, including:
- Diabetes is characterized by hyperglycemia due to defects in insulin secretion or action. The incidence is increasing globally.
- There are three main types: type 1 caused by autoimmune destruction of beta cells; type 2 associated with insulin resistance; and other specific types.
- Treatment goals are to prevent complications and death through education, insulin therapy, diet, exercise and monitoring of blood glucose and HbA1c levels.
The document discusses diabetes, including:
- Diabetes is characterized by hyperglycemia due to defects in insulin secretion or action. The incidence is increasing globally.
- There are three main types: type 1 caused by autoimmune destruction of beta cells; type 2 associated with insulin resistance; and other specific types.
- Treatment goals are to prevent complications and death through education, insulin therapy, diet, exercise and monitoring of blood glucose and HbA1c levels.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 27
Diabetes
melitus Definition Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both
Diabetes Care January 2013 vol. 36 no. Supplement 1 S67-S74
Epidemiologi Incidence of diabetes is alarmingly increasing all over the globe. Prevalence of childhood diabetes range between 3-50/100,000 worldwide; . Dana Dabelea (2014): Type 1 DM in 2001 = 1,48/1000 2009 = 1,93/1000 Type 2 DM in 2001 = 0,34/1000 2009 = 0,46/1000 Dana Dabelea. Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents from 2001 to 2009. JAMA.2014 WHO CLASSIFICATION 2000 Is based on etiology not on type of treatment or age of the patient. Type 1 Diabetes (idiopathic or autoimmune b-cell destruction) Type 2 Diabetes (insulin resistance) Other specific types Classification • B cell Pancreas destruction DM tipe 1 • Absolute insulin deficiency
• Kombinasi resistensi insulin dan inadekuat
DM Tipe 2 sekresi insulin
• Pancreas Exocrin desease, Pancreas Fibrous
DM tipe lain Cystic, drugs
DM Gestasional Diabetes yang mucul saat kehamilan
Common symptoms of diabetes: Polidipsi Poliuri Polifagi Blurry vision Cuts/bruises that are slow to heal Weight loss - even though you are eating more (type 1) Pain or numbness in the hands/feet Diagnostic Criteria Fastingplasma glucose (FPG) ≥ 126 mg/dl (7.0 mmol/l); OR Symptoms (such as polyuria, polydipsia, unexplained weight loss) AND a random plasma glucose > 200 mg/dl (11.1 mmol/l); OR Random plasma glucose > 200 mg/dl (1.1 mmol/l) 2 hours after a 75g glucose load TYPE 1 DIABETES: ETIOLOGY
Type 1 diabetes mellitus mostly caused by
autoimmune disease. Islet cell autoantibodies Glutamic acid decarboksilase AUTOIMMUNITY Circulating antibodies against b-cells and insulin. Immunofluorescent antibodies & lymphocyte infiltration around pancreatic islet cells. Evidence of immune system activation. Circulating immune complexes with high IgA & low interferon levels. Association with other autoimmune diseases. Screening for T1 The reason to screen and intervene early in T1D:
Common, serious in terms of morbidity and
mortality Latency period without symptoms Screening test with sensitivity and specificity Intervention early is more effective, preserves C-peptide HONEYMOON PERIOD Due to b-cell reserve optimal function & initiation of insulin therapy. Leads to normal blood glucose level without exogenous insulin. Observed in 50-60% of newly diagnosed patients & it can last up to one year but it always ends. Can confuse patients & parents if not educated about it early. COMPLICATIONS OF DIABETES Acute: DKA Hypoglycemia Late-onset: Retinopathy Neuropathy Nephropathy Ischemic heart disease & stroke TREATMENT GOALS
Prevent death & alleviate symptoms
Achieve biochemical control Maintain growth & development Prevent acute complications Prevent or delay late-onset complications TREATMENT ELEMENTS Education Insulintherapy Diet and meal planning Monitoring HbA1c every 2-months Home regular BG monitoring Home urine ketones tests when indicated FUNCTION OF INSULIN Insulin being an anabolic hormone stimulates protein & fatty acids synthesis. Insulin decreases blood sugar 1. By inhibiting hepatic glycogenolysis and gluconeogenesis. 2. By stimulating glucose uptake, utilization & storage by the liver, muscles & adipose tissue. TYPES OF INSULIN Shortacting (neutral, soluble, regular) Peak 2-3 hours & duration up to 8 hours Intermediate acting Isophane (peak 6-8 h & duration 16-24 h) Biphasic (peak 4-6 h & duration 12-20 h) Semilente (peak 5-7 h & duration 12-18 h) Long acting (lente, ultralente & PZI) Peak 8-14 h & duration 20-36 h EXERCISE Decreases insulin requirement in diabetic subjects by increasing both sensitivity of muscle cells to insulin & glucose utilization. It can precipitate hypoglycemia in the unprepared diabetic patient. It may worsen pre-existing diabetic retinopathy. MONITORING Compliance (check records) Home Reguler Blood Glucose tests HbA1 every 2 months Insulin & meal plan Growth & development Well being & life style School & hobbies